These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22316315)

  • 1. Comparison of vaginal gel isoflavones versus no topical treatment in vaginal dystrophy: results of a preliminary prospective study.
    Tedeschi C; Benvenuti C;
    Gynecol Endocrinol; 2012 Aug; 28(8):652-4. PubMed ID: 22316315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
    Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S
    Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women.
    Colacurci N; De Franciscis P; Atlante M; Mancino P; Monti M; Volpini G; Benvenuti C
    Gynecol Endocrinol; 2013 Mar; 29(3):209-12. PubMed ID: 23194023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: A systematic review of randomised controlled trials.
    Ghazanfarpour M; Latifnejad Roudsari R; Treglia G; Sadeghi R
    J Obstet Gynaecol; 2015; 35(8):783-7. PubMed ID: 25710207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nettle vaginal cream on subjective symptoms of vaginal atrophy in postmenopausal women.
    Karimi FZ; Nazari N; Rakhshandeh H; Mazloum SR
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():41-45. PubMed ID: 37044017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
    Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
    J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S; Grüntkemeier L; Häuser M; May TW; Masur C; Stute P
    PLoS One; 2022; 17(5):e0266633. PubMed ID: 35551533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
    Morali G; Polatti F; Metelitsa EN; Mascarucci P; Magnani P; Marrè GB
    Arzneimittelforschung; 2006; 56(3):230-8. PubMed ID: 16618016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monurelle Biogel
    Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
    Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
    Simon JA; Maamari RV
    Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
    Jonasson AF; Edwall L; Uvnäs-Moberg K
    Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study.
    Chatsiproios D; Schmidts-Winkler IM; König L; Masur C; Abels C
    PLoS One; 2019; 14(1):e0210967. PubMed ID: 30677065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
    Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
    Archer DF
    J Steroid Biochem Mol Biol; 2015 Jan; 145():139-43. PubMed ID: 25201455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.